Schizophrenia & Psychotic Disorders

Neonatal vitamin D deficiency is associated with a 44% increased risk of schizophrenia later in life, according to a study published in Scientific Reports.


CAINS scale

The Clinical Assessment Interview for Negative Systems (CAINS) is an effective, empirically developed, and validated tool for measuring negative symptoms in schizophrenia, according to Ann M. Kring, PhD, of the University of California in Berkeley, and colleagues.

Within a few short months last year, our country mourned unimaginable losses suffered in two mass shootings that collectively took the lives of 38 adults and children — the Sandy Hook Elementary School shooting in Newtown, Connecticut, and the movie theater massacr

Research shows that the newer “atypical” or second-generation antipsychotic medications are associated with a host of metabolic side effects. This article explores whether clinicians are doing enough to monitor patients, how to develop an effective monitoring system, and how to intervene once a problem is identified.

Patients with schizophrenia are likely to die 12 to 15 years earlier than the general population, and this difference in mortality is largely due to undiagnosed ischemic heart disease and cancer, according to a study published in the January 15 American Journal of Psychiatry.

During periods of drug use, patients who abuse methamphetamine are substantially more likely to experience psychotic symptoms, researchers reported in a longitudinal study published in the January 9 online JAMA Psychiatry.